Infinity Pharmaceuticals, Inc. Increase (Decrease) in Unbilled Receivables
Infinity Pharmaceuticals, Inc. reported Increase (Decrease) in Unbilled Receivables of -$218.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2015-02-24.
Discontinued › Notes
us-gaap:IncreaseDecreaseInUnbilledReceivables · last filed 2015-02-24
- Infinity Pharmaceuticals, Inc. increase (decrease) in unbilled receivables for the quarter ending 2012-12-31 was $0.00.
- Infinity Pharmaceuticals, Inc. increase (decrease) in unbilled receivables for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- Infinity Pharmaceuticals, Inc. increase (decrease) in unbilled receivables for the quarter ending 2012-06-30 was -$237.00K.
- Infinity Pharmaceuticals, Inc. increase (decrease) in unbilled receivables for the quarter ending 2012-03-31 was $19.00K.
- Infinity Pharmaceuticals, Inc. increase (decrease) in unbilled receivables for fiscal 2012 was -$218.00K, a 200.00% decline from fiscal 2011.
- Infinity Pharmaceuticals, Inc. increase (decrease) in unbilled receivables for fiscal 2011 was $218.00K.
| Period end | Increase (Decrease) in Unbilled Receivables 3 month | Increase (Decrease) in Unbilled Receivables 6 month | Increase (Decrease) in Unbilled Receivables 6 month as first filed | Increase (Decrease) in Unbilled Receivables 9 month | Increase (Decrease) in Unbilled Receivables 9 month as first filed | Increase (Decrease) in Unbilled Receivables 12 month |
|---|---|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | -$237.00K derived: sum of 3 quarters · filed 2015-02-24 | -$218.00K 10-K · filed 2015-02-24 | ||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$237.00K derived: sum of 2 quarters · filed 2013-11-07 | -$218.00K 10-Q · filed 2013-11-07 | -$716.00K derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-06-30 | -$237.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$218.00K 10-Q · filed 2013-08-08 | -$716.00K derived: sum of 3 quarters · filed 2014-02-25 | -$69.00K derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-03-31 | $19.00K 10-Q · filed 2013-05-07 | -$479.00K derived: sum of 2 quarters · filed 2014-02-25 | $168.00K derived: sum of 3 quarters · filed 2014-02-25 | |||
| 2011-12-31 | -$498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $149.00K derived: sum of 2 quarters · filed 2014-02-25 | $218.00K 10-K · filed 2014-02-25 | |||
| 2011-09-30 | $647.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $716.00K 10-Q · filed 2012-11-06 | $715.64K 10-Q · filed 2011-11-08 | |||
| 2011-06-30 | $69.00K 10-Q · filed 2012-08-07 | $69.18K 10-Q · filed 2011-08-09 | ||||
| 2010-09-30 | $5.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $5.58M 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | $387.12K 10-Q · filed 2011-08-09 |